Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo

Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo

Xin Wu,1,2,* Zongguang Tai,1,* Quangang Zhu,3,* Wei Fan,4 Baoyue Ding,5 Wei Zhang,1,6 Lijuan Zhang,1 Chong Yao,1 Xiaoyu Wang,1 Xueying Ding,2 Qin Li,2 Xiaoyu Li,2 Gaolin Liu,2 Jiyong Liu,1 Shen Gao1 1Department of Pharmaceutics, Changhai Hospital, Second Military Medical University, 2Department of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wu X, Tai Z, Zhu Q, Fan W, Ding B, Zhang W, Zhang L, Yao C, Wang X, Ding X, Li Q, Li X, Liu G, Liu J, Gao S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/f467e5546b59437f92ac6bf86f2a2d8e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f467e5546b59437f92ac6bf86f2a2d8e
record_format dspace
spelling oai:doaj.org-article:f467e5546b59437f92ac6bf86f2a2d8e2021-12-02T00:39:21ZStudy on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo1178-2013https://doaj.org/article/f467e5546b59437f92ac6bf86f2a2d8e2014-11-01T00:00:00Zhttp://www.dovepress.com/study-on-the-prostate-cancer-targeting-mechanismnbspof-aptamer-modifie-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Xin Wu,1,2,* Zongguang Tai,1,* Quangang Zhu,3,* Wei Fan,4 Baoyue Ding,5 Wei Zhang,1,6 Lijuan Zhang,1 Chong Yao,1 Xiaoyu Wang,1 Xueying Ding,2 Qin Li,2 Xiaoyu Li,2 Gaolin Liu,2 Jiyong Liu,1 Shen Gao1 1Department of Pharmaceutics, Changhai Hospital, Second Military Medical University, 2Department of Pharmaceutics, Shanghai First People’s Hospital, Shanghai Jiaotong University School of Medicine, 3Department of Pharmaceutics, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 4Department of Pharmaceutics, The 425th Hospital of PLA, Sanya, People’s Republic of China; 5Department of Pharmaceutics, Medical College of Jiaxing University, Jiaxing, People’s Republic of China; 6Department of Pharmaceutics, The 522nd Hospital of PLA, Luoyang, People’s Republic of China *These authors contributed equally to this work Abstract: Ligand-mediated prostate cancer (PCa)-targeting gene delivery is one of the focuses of research in recent years. Our previous study reported the successful preparation of aptamer-modified nanoparticles (APT-NPs) in our laboratory and demonstrated their PCa-targeting ability in vitro. However, the mechanism underlying this PCa-targeting effect and their anticancer ability in vivo have not yet been elucidated. The objective of this study was to assess the feasibility of using APT-NPs to deliver micro RNA (miRNA) systemically to PCa cells, to testify their tumor-targeting efficiency, and to observe their biodistribution after systemic administration to a xenograft mouse model of PCa. In addition, the effect of APT depletion and endocytosis inhibitors on cellular uptake was also evaluated quantitatively in LNCaP cells to explore the internalization mechanism of APT-NPs. Finally, blood chemistry, and renal and liver function parameters were measured in the xenograft mouse model of PCa to see whether APT-NPs had any demonstrable toxicity in mice in vivo. The results showed that APT-NPs prolonged the survival duration of the PCa tumor-bearing mice as compared with the unmodified NPs. In addition, they had a potential PCa-targeting effect in vivo. In conclusion, this research provides a prototype for the safe and efficient delivery of miRNA expression vectors to PCa cells, which may prove useful for preclinical and clinical studies on the treatment of PCa. Keywords: miRNA, aptamer, polyamidoamine, prostate-specific membrane antigen, targeted delivery, prostate cancerWu XTai ZZhu QFan WDing BZhang WZhang LYao CWang XDing XLi QLi XLiu GLiu JGao SDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 5431-5440 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Wu X
Tai Z
Zhu Q
Fan W
Ding B
Zhang W
Zhang L
Yao C
Wang X
Ding X
Li Q
Li X
Liu G
Liu J
Gao S
Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
description Xin Wu,1,2,* Zongguang Tai,1,* Quangang Zhu,3,* Wei Fan,4 Baoyue Ding,5 Wei Zhang,1,6 Lijuan Zhang,1 Chong Yao,1 Xiaoyu Wang,1 Xueying Ding,2 Qin Li,2 Xiaoyu Li,2 Gaolin Liu,2 Jiyong Liu,1 Shen Gao1 1Department of Pharmaceutics, Changhai Hospital, Second Military Medical University, 2Department of Pharmaceutics, Shanghai First People’s Hospital, Shanghai Jiaotong University School of Medicine, 3Department of Pharmaceutics, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 4Department of Pharmaceutics, The 425th Hospital of PLA, Sanya, People’s Republic of China; 5Department of Pharmaceutics, Medical College of Jiaxing University, Jiaxing, People’s Republic of China; 6Department of Pharmaceutics, The 522nd Hospital of PLA, Luoyang, People’s Republic of China *These authors contributed equally to this work Abstract: Ligand-mediated prostate cancer (PCa)-targeting gene delivery is one of the focuses of research in recent years. Our previous study reported the successful preparation of aptamer-modified nanoparticles (APT-NPs) in our laboratory and demonstrated their PCa-targeting ability in vitro. However, the mechanism underlying this PCa-targeting effect and their anticancer ability in vivo have not yet been elucidated. The objective of this study was to assess the feasibility of using APT-NPs to deliver micro RNA (miRNA) systemically to PCa cells, to testify their tumor-targeting efficiency, and to observe their biodistribution after systemic administration to a xenograft mouse model of PCa. In addition, the effect of APT depletion and endocytosis inhibitors on cellular uptake was also evaluated quantitatively in LNCaP cells to explore the internalization mechanism of APT-NPs. Finally, blood chemistry, and renal and liver function parameters were measured in the xenograft mouse model of PCa to see whether APT-NPs had any demonstrable toxicity in mice in vivo. The results showed that APT-NPs prolonged the survival duration of the PCa tumor-bearing mice as compared with the unmodified NPs. In addition, they had a potential PCa-targeting effect in vivo. In conclusion, this research provides a prototype for the safe and efficient delivery of miRNA expression vectors to PCa cells, which may prove useful for preclinical and clinical studies on the treatment of PCa. Keywords: miRNA, aptamer, polyamidoamine, prostate-specific membrane antigen, targeted delivery, prostate cancer
format article
author Wu X
Tai Z
Zhu Q
Fan W
Ding B
Zhang W
Zhang L
Yao C
Wang X
Ding X
Li Q
Li X
Liu G
Liu J
Gao S
author_facet Wu X
Tai Z
Zhu Q
Fan W
Ding B
Zhang W
Zhang L
Yao C
Wang X
Ding X
Li Q
Li X
Liu G
Liu J
Gao S
author_sort Wu X
title Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
title_short Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
title_full Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
title_fullStr Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
title_full_unstemmed Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
title_sort study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/f467e5546b59437f92ac6bf86f2a2d8e
work_keys_str_mv AT wux studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT taiz studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT zhuq studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT fanw studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT dingb studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT zhangw studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT zhangl studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT yaoc studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT wangx studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT dingx studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT liq studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT lix studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT liug studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT liuj studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
AT gaos studyontheprostatecancertargetingmechanismnbspofaptamermodifiednanoparticlesandtheirpotentialanticancereffectinvivo
_version_ 1718403592266711040

Ejemplares similares